Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Shares Outstanding (Diluted Average): 2016-2018

Historic Shares Outstanding (Diluted Average) for Outlook Therapeutics (OTLK) over the last 3 years, with Sep 2018 value amounting to $39.5 million.

  • Outlook Therapeutics' Shares Outstanding (Diluted Average) was N/A to $90.8 million in Q2 2020 from the same period last year, while for Jun 2020 it was $90.8 million, marking a year-over-year change of. This contributed to the annual value of $39.5 million for FY2018, which is 64.12% up from last year.
  • Per Outlook Therapeutics' latest filing, its Shares Outstanding (Diluted Average) stood at $39.5 million for FY2018, which was up 64.12% from $24.0 million recorded in FY2017.
  • In the past 5 years, Outlook Therapeutics' Shares Outstanding (Diluted Average) ranged from a high of $39.5 million in FY2018 and a low of $17.2 million during FY2016.
  • For the 3-year period, Outlook Therapeutics' Shares Outstanding (Diluted Average) averaged around $26.9 million, with its median value being $24.0 million (2017).
  • Data for Outlook Therapeutics' Shares Outstanding (Diluted Average) shows a peak YoY soared of 64.12% (in 2018) over the last 5 years.
  • Yearly analysis of 3 years shows Outlook Therapeutics' Shares Outstanding (Diluted Average) stood at $17.2 million in 2016, then surged by 39.67% to $24.0 million in 2017, then soared by 64.12% to $39.5 million in 2018.